
Isomorphic Labs raises $5 billion for AI drug discovery
Signals:
- →$5B Series C signals strong investor confidence in AI-driven drug discovery.
- →Isomorphic scaling IsoDDE and AI-designed pipeline, intensifying pharma AI competition.
- →Major capital and Alphabet backing may reshape partnerships, talent, and therapeutic development timelines.






